Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426774 · ClinicalTrials.gov registry record · NA
Simulated Passive Jogging & Jumping Devices & NO
A NA study, sponsored by Sackner Wellness Products.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03426774: Completed NA study, sponsored by Sackner Wellness Products.
NCT03426774 is a NA study that has completed, run by Sackner Wellness Products. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03426774, a NA study, has completed, sponsored by Sackner Wellness Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Movement is important for overall health. Lack of movement has been shown to be associated with numerous diseases. This study will assess the validity and usefulness of two innovative low risk, non-invasive wellness devices, the Gentle Jogger® and the Gentle Jumper that passively simulate the physical activities of jogging and jumping, respectively. The study will evaluate whether or not each of the devices in different body postures (seated, lying down, slight recumbent and slight head down) produces changes in blood pressure, and indices of dilatation of blood vessels, in a younger (25-59yr) and older (\> 60 yrs.) subject population. Volunteers will be paid for their participation in the study. A substudy of this larger study ( Effects of Gentle Jogger on blood pressure), will determine the effects of 30 min of gentle jogger in seated and supine posture compared to Sham
Primary Outcome
Determination of the change in a/b ratio from the non invasively acquired arterial pulse waveform
Interventions
- DEVICE Gentle Jogger
- DEVICE Gentle Jumper
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2020-01-23 |
| Phase | NA |
What the finished NCT03426774 record still lists
NCT03426774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Gentle Jogger is the first listed.
NCT03426774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03426774 about?
NCT03426774 is a clinical study titled "Simulated Passive Jogging & Jumping Devices & NO". Movement is important for overall health. Lack of movement has been shown to be associated with numerous diseases. This study will assess the validity and usefulness of two innovative low risk, non-invasive wellness devices, the Gentle Jogger® and the Gentle Jumper that passively simulate the physic...
What is the current status of trial NCT03426774?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-03-01. Estimated completion is 2020-01-23.
What interventions are being tested in trial NCT03426774?
The interventions under investigation include: Gentle Jogger (DEVICE), Gentle Jumper (DEVICE).
Who is sponsoring clinical trial NCT03426774?
This trial is sponsored by Sackner Wellness Products, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03426774's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI